We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

CC Imaging Capsule Requires No Colon Preparation

By MedImaging International staff writers
Posted on 14 Jan 2020
Print article
Image: The Check-Cap prepless disposable capsule (Photo courtesy of Check-Cap)
Image: The Check-Cap prepless disposable capsule (Photo courtesy of Check-Cap)
A new preparation-free ingestible scanning capsule helps prevent colorectal cancer (CC) through the detection of precancerous polyps.

The Check-Cap (Isfiya, Israel) C-Scan System is comprised of an ultra-low dose X-ray capsule, an integrated positioning, control, and recording system, and proprietary software that is used to generate a three dimensional (3D) map of the inner lining of the colon. The heart of the system is the C-Scan Cap, an ingestible imaging capsule consisting of X-ray source that is collimated and rotated, forming three beams that scan the colon from within. Radiofrequency (RF) communication transmits the data to C-Scan Track, a tracking control and data collection unit comprised of three external patches that are worn on the patient's back.

C-Scan Track consists of an integrated positioning, control, and recording system that continuously tracks the capsule’s position and orientation along the colon, activates the capsule's scanning function during movement in the colon, and records and stores the capsule's information for future download. As the patient continues normal daily activities, the capsule is propelled through the gastrointestinal tract by natural motility, while continuously measuring the internal circumferential dimensions and tracking the position and orientation of the capsule within the body. The information is later used by C-Scan View to construct 2D and 3D images of the colon surface.

Patients swallow the capsule together with one tablespoon of radiopaque contrast solution; no fasting or bowel preparation is required. When C-Scan Cap has completed its passage, it is naturally excreted from the patient's body. The X-ray dose to which patients are exposed to for the entire procedure, from ingestion to excretion of the capsule, is similar to that of a single chest radiograph, significantly lower than conventional medical imaging procedures using X-rays such as computed tomography (CT) of the abdomen and pelvis and screening mammography.

“Check-Cap's prep-free, non-invasive technology meets the real need for colon cancer screening that's easy for patients. Patients are often hesitant to undergo colonoscopy due to the preparation, sedation, general discomfort and potential risks,” said Professor Oscar Lebwohl, MD, of Columbia University (New York, NY, USA). “If further studies demonstrate that Check-Cap is an accurate screening modality for colon cancer and polyps, then the Check-Cap system will be a viable testing alternative, allowing the screening of patients in greater numbers and the use of fewer resources compared with CTC and Colonoscopy.”

Related Links:
Check-Cap

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Digital Radiography Generator
meX+20BT lite
Color Doppler Ultrasound System
DRE Crystal 4PX

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more